Advanced search
Publication Cover
Lung Cancer: Targets and Therapy Volume 14, 2023 - Issue
Submit an article Journal homepage
358
Views
0
CrossRef citations to date
0
Altmetric
PERSPECTIVES

ALESIA 5-Year Update: Alectinib at 600 mg Twice Daily Gives Lorlatinib a Run for Its Money in Asia

Alexandria TM Lee1 Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USAORCID Iconhttps://orcid.org/0000-0002-2618-8131
ORCID Icon &
Saihong Ignatius Ou1 Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USA;2 Chao Family Comprehensive Cancer Center, Orange, CA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1764-4975
ORCID Icon
Pages 71-78 | Received 30 Apr 2023, Accepted 02 Jul 2023, Published online: 07 Jul 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.